MELOXICAM Safety Questions, MELOXICAM Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about MELOXICAM. Our extensive database of MELOXICAM adverse events and MELOXICAM warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Ask Our Health Experts about MELOXICAM
MELOXICAM Safety Reports
Total MELOXICAM reports: 39.MELOXICAM FDA safety alerts: No.
Reported deaths: 8 Reported hospitalizations: 14.
Take MELOXICAM Side Effects Survey or Share Your MELOXICAM Story. MELOXICAM Usage.
Health Professional from UNITED STATES reported MELOXICAM problem on Jan 18, 2007. Female patient, 80 years of age, weighting 133.0 lb, was diagnosed with osteoarthritis and was treated with MELOXICAM. After drug was administered, patient experienced the following problems/side effects: arthralgia, condition aggravated. MELOXICAM dosage: 10MG DAILY PO. During the same period patient was treated with GLUCOSAMINE. Patient recovered.
MELOXICAM problem was reported by a Consumer or non-health professional from POLAND on Jan 11, 2007. Female patient, 92 years of age, was diagnosed with osteoarthritis and was treated with MELOXICAM. After drug was administered, patient experienced the following problems/side effects: metrorrhagia. MELOXICAM dosage: 15 MG. During the same period patient was treated with DIGOXIN, CARVEDILOL, AMILORIDE AND HYDROCHLOROTHIAZIDE. Patient recovered.
Consumer or non-health professional from reported MELOXICAM problem on Jan 29, 2007. Female patient, 38 years of age, was diagnosed with allergy test and was treated with MELOXICAM. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction, urticaria. MELOXICAM dosage: unknown. During the same period patient was treated with ACETYLSALICYLIC ACID, ACETAMINOPHEN, NSAID. Patient recovered.
MELOXICAM problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Jan 16, 2007. Female patient, 50 years of age, was treated with MELOXICAM. After drug was administered, patient experienced the following problems/side effects: cognitive disorder, confusional state, dizziness, nausea, rash, somnolence, visual disturbance, vomiting. MELOXICAM dosage: 7.5 MG (7.5 MG, 1 IN 1 D); ORAL. Patient recovered.
Health Professional from UNITED STATES reported MELOXICAM problem on Feb 16, 2007. Female patient, 59 years of age, weighting 135.0 lb, was diagnosed with exostosis, tendonitis and was treated with MELOXICAM. After drug was administered, patient experienced the following problems/side effects: eyelid oedema, skin discolouration, skin exfoliation. MELOXICAM dosage: 15MG QD PO. Patient recovered.
MELOXICAM problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 12, 2007. Female patient, 66 years of age, was diagnosed with arthralgia and was treated with MELOXICAM. After drug was administered, patient experienced the following problems/side effects: duodenal perforation, duodenal ulcer haemorrhage. MELOXICAM dosage: 15 MG; QD; PO. During the same period patient was treated with CLOPIDOGREL, DILTIAZEM, SIMVASTATIN, LEVOTHYROXINE. Patient was hospitalized. Patient recovered.
Physician from UNITED STATES reported MELOXICAM problem on Mar 02, 2007. Female patient, weighting 187.0 lb, was diagnosed with rheumatoid arthritis and was treated with MELOXICAM. After drug was administered, patient experienced the following problems/side effects: condition aggravated, lymphoedema. MELOXICAM dosage: 15 MG ONCE DAILY PO. Patient recovered.
MELOXICAM problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Feb 27, 2007. Female patient, 63 years of age, was diagnosed with rheumatoid arthritis and was treated with MELOXICAM. After drug was administered, patient experienced the following problems/side effects: barrett's oesophagus, chest pain, duodenal ulcer, duodenitis, helicobacter pylori identification test positive, vomiting. MELOXICAM dosage: 15 MG; QD; PO. During the same period patient was treated with ASPIRIN, PREDISOLONE, RISEDRONIC ACID, OMEPRAZOLE, ISOSORBIDE MONONITRATE, SALBUTAMOL, ALIMEMAZINE. Patient was hospitalized. Patient recovered.
Health Professional from UNITED KINGDOM reported MELOXICAM problem on Feb 27, 2007. Female patient, 63 years of age, was diagnosed with rheumatoid arthritis and was treated with MELOXICAM. After drug was administered, patient experienced the following problems/side effects: barrett's oesophagus, chest pain, duodenal ulcer, duodenitis, helicobacter pylori identification test positive, vomiting. MELOXICAM dosage: 15 MG (15 MG, 1 IN 1 D). During the same period patient was treated with PREDNISOLONE, ACETYLSALICYLIC ACID SRT, RISEDRONATE. Patient was hospitalized. Patient recovered.
MELOXICAM problem was reported by a Pharmacist from UNITED STATES on Mar 21, 2007. Male patient, 70 years of age, weighting 213.4 lb, was treated with MELOXICAM. After drug was administered, patient experienced the following problems/side effects: haematemesis, melaena. MELOXICAM dosage: 15 MG PO DAILY. Patient was hospitalized. Patient recovered.
Physician from UNITED STATES reported MELOXICAM problem on Mar 26, 2007. Female patient was diagnosed with colorectal cancer metastatic and was treated with MELOXICAM. MELOXICAM dosage: unknown. During the same period patient was treated with EZETIMIBE, VALSARTAN, FLUOROURACIL, BEVACIZUMAB, ELOXATIN, FLONASE, ASPIRIN, NIACIN. Patient died on 02/16/2007.
MELOXICAM problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 09, 2007. Male patient, 58 years of age, weighting 201.5 lb, was treated with MELOXICAM. After drug was administered, patient experienced the following problems/side effects: joint swelling. MELOXICAM dosage: unknown. Patient recovered.
Consumer or non-health professional from UNITED STATES reported MELOXICAM problem on May 08, 2007. Female patient, 72 years of age, weighting 200.0 lb, was diagnosed with traumatic arthritis and was treated with MELOXICAM. After drug was administered, patient experienced the following problems/side effects: inadequate analgesia. MELOXICAM dosage: unknown. Patient recovered.
MELOXICAM problem was reported by a Consumer or non-health professional from on May 09, 2007. Female patient, 65 years of age, was diagnosed with rheumatoid arthritis and was treated with MELOXICAM. After drug was administered, patient experienced the following problems/side effects: abdominal pain, anaemia, anal haemorrhage, colitis, diarrhoea, haematochezia. MELOXICAM dosage: unknown. Patient was hospitalized. Patient died.
Consumer or non-health professional from UNITED KINGDOM reported MELOXICAM problem on May 18, 2007. Male patient, 71 years of age, was diagnosed with gout and was treated with MELOXICAM. After drug was administered, patient experienced the following problems/side effects: dehydration, diarrhoea, dizziness, metabolic acidosis, renal failure acute, renal impairment. MELOXICAM dosage: 7.5 MG; QD; PO. During the same period patient was treated with LISINOPRIL, LERCANIDIPINE, ALLOPURINOL, LANSOPRAZOLE, TIMOLOL MALEATE. Patient was hospitalized. Patient recovered.
MELOXICAM problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 02, 2007. Male patient was diagnosed with arthritis and was treated with MELOXICAM. After drug was administered, patient experienced the following problems/side effects: dysarthria, swollen tongue. MELOXICAM dosage: (7.5 MG), ORAL. Patient recovered.
Consumer or non-health professional from reported MELOXICAM problem on Aug 21, 2006. Female patient, 65 years of age, was diagnosed with rheumatoid arthritis and was treated with MELOXICAM. After drug was administered, patient experienced the following problems/side effects: abdominal pain, anaemia, anal haemorrhage, colitis, diarrhoea, haematochezia. MELOXICAM dosage: unknown. Patient was hospitalized. Patient died.
MELOXICAM problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Aug 22, 2006. Female patient, 71 years of age, was diagnosed with arthralgia, hiatus hernia and was treated with MELOXICAM. After drug was administered, patient experienced the following problems/side effects: systemic lupus erythematosus. MELOXICAM dosage: 15 MILLIGRAMS ORAL. During the same period patient was treated with LANSOPRAZOLE, LOFEPRAMINE HYDROCHLORIDE. Patient recovered.
Consumer or non-health professional from UNITED STATES reported MELOXICAM problem on Sept 18, 2006. Male patient, 61 years of age, weighting 250.0 lb, was diagnosed with analgesic effect and was treated with MELOXICAM. After drug was administered, patient experienced the following problems/side effects: myocardial infarction. MELOXICAM dosage: 15 MG DAILY. Patient was hospitalized and became disabled. Patient recovered.
MELOXICAM problem was reported by a Health Professional from UNITED STATES on Nov 07, 2006. Female patient, 51 years of age, weighting 135.0 lb, was diagnosed with osteoarthritis and was treated with MELOXICAM. After drug was administered, patient experienced the following problems/side effects: gastric ulcer, movement disorder, pain. MELOXICAM dosage: unknown. During the same period patient was treated with ACIPHEX, NEXIUM. Patient recovered.
Physician from UNITED STATES reported MELOXICAM problem on Oct 24, 2006. Female patient, 42 years of age, was treated with MELOXICAM. After drug was administered, patient experienced the following problems/side effects: completed suicide. MELOXICAM dosage: unknown. During the same period patient was treated with AMLODIPINE, FEXOFENADINE. Patient died.
MELOXICAM problem was reported by a Consumer or non-health professional from on Aug 21, 2006. Female patient, 65 years of age, was diagnosed with rheumatoid arthritis and was treated with MELOXICAM. After drug was administered, patient experienced the following problems/side effects: abdominal pain, anaemia, anal haemorrhage, colitis, diarrhoea, haematochezia. MELOXICAM dosage: unknown. Patient was hospitalized. Patient died.
Consumer or non-health professional from reported MELOXICAM problem on Dec 12, 2006. Male patient, 56 years of age, was diagnosed with spondyloarthropathy, colitis ulcerative and was treated with MELOXICAM. After drug was administered, patient experienced the following problems/side effects: anorexia, malaise, pyrexia, renal failure, tubulointerstitial nephritis. MELOXICAM dosage: unknown. During the same period patient was treated with SALOFALK. Patient was hospitalized. Patient recovered.
MELOXICAM problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Dec 04, 2006. Female patient, 66 years of age, was diagnosed with arthralgia and was treated with MELOXICAM. After drug was administered, patient experienced the following problems/side effects: duodenal perforation, duodenal ulcer haemorrhage. MELOXICAM dosage: 15 MG;QD;PO. During the same period patient was treated with CLOPIDOGREL, DILTIAZEM, SIMVASTATIN, LEVOTHYROXINE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported MELOXICAM problem on Dec 08, 2006. Female patient, 51 years of age, was diagnosed with arthritis and was treated with MELOXICAM. After drug was administered, patient experienced the following problems/side effects: vaginal haemorrhage. MELOXICAM dosage: unknown. Patient recovered.
MELOXICAM problem was reported by a Health Professional from UNITED KINGDOM on July 31, 2007. Female patient, 70 years of age, was treated with MELOXICAM. After drug was administered, patient experienced the following problems/side effects: blood pressure increased, cardiac flutter, diarrhoea, epistaxis, fatigue, heart rate increased, hypertension, tremor. MELOXICAM dosage: 7.5 MG; QD; PO. During the same period patient was treated with ACOMPLIA, LEVOTHYROXINE, ATROVENT, QVAR, METFORMIN, ZOPICLONE, MIZOLASTINE, NEDOCROMIL. Patient recovered.
Physician from UNITED STATES reported MELOXICAM problem on Aug 20, 2007. Female patient, weighting 221.0 lb, was diagnosed with arthralgia and was treated with MELOXICAM. After drug was administered, patient experienced the following problems/side effects: fall, muscular weakness. MELOXICAM dosage: 15 MG QD PO. Patient recovered.
MELOXICAM problem was reported by a Health Professional from UNITED KINGDOM on Aug 14, 2007. Female patient, 70 years of age, was treated with MELOXICAM. After drug was administered, patient experienced the following problems/side effects: cardiac flutter, diarrhoea, epistaxis, fatigue, heart rate increased, hypertension, tremor. MELOXICAM dosage: 7.5 MG; QD; PO. During the same period patient was treated with ACOMPLIA, LEVOTHYROXINE, ATROVENT, QVAR, METFORMIN, ZOPICLONE, MIZOLASTINE, NEDOCROMIL. Patient recovered.
Consumer or non-health professional from UNITED KINGDOM reported MELOXICAM problem on July 30, 2007. Female patient, 70 years of age, was diagnosed with obesity and was treated with MELOXICAM. After drug was administered, patient experienced the following problems/side effects: cardiac flutter, diarrhoea, epistaxis, fatigue, heart rate increased, hypertension, tremor. MELOXICAM dosage: 7,5 MG (7,5 MG,1 IN 1 D) ORAL. During the same period patient was treated with ACCOMPLIA, ATROVENT, FELDENE, LEVOTHIROXINE, METFORMIN, MIZOLASTINE, MOMETASONE, NEDOCROMIL. Patient recovered.
MELOXICAM problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Aug 21, 2007. Female patient, 70 years of age, was treated with MELOXICAM. After drug was administered, patient experienced the following problems/side effects: cardiac flutter, diarrhoea, epistaxis, fatigue, heart rate increased, hypertension, tremor, weight decreased. MELOXICAM dosage: 7.5 MG; QD; PO. During the same period patient was treated with ACOMPLIA, LEVOTHYROXINE, ATROVENT, QVAR, MEFORMIN, ZOPICLONE, MIZOLASTINE, NEDOCROMIL. Patient recovered.
Consumer or non-health professional from UNITED STATES reported MELOXICAM problem on Apr 02, 2007. Female patient was treated with MELOXICAM. After drug was administered, patient experienced the following problems/side effects: fungal infection, hepatic enzyme increased, hepatitis c antibody, oedema peripheral, weight increased. MELOXICAM dosage: unknown. During the same period patient was treated with PREDNISONE, TEGASEROD, FLUCONAZOLE, AMOXICILLIN. Patient was hospitalized. Patient recovered.
MELOXICAM problem was reported by a Physician from UNITED STATES on Sept 05, 2007. Female patient, weighting 169.0 lb, was treated with MELOXICAM. After drug was administered, patient experienced the following problems/side effects: arthralgia, joint swelling. MELOXICAM dosage: unknown. During the same period patient was treated with LODINE, MOTRIN, RELAFEN, FELDENE, NAPROXEN, VIOXX. Patient recovered.
Consumer or non-health professional from UNITED STATES reported MELOXICAM problem on Aug 27, 2007. Female patient, 54 years of age, was diagnosed with osteoarthritis and was treated with MELOXICAM. After drug was administered, patient experienced the following problems/side effects: dizziness, headache, influenza like illness, nausea. MELOXICAM dosage: unknown. Patient recovered.
MELOXICAM problem was reported by a Health Professional from UNITED KINGDOM on Aug 29, 2007. Male patient, 71 years of age, was diagnosed with gout and was treated with MELOXICAM. After drug was administered, patient experienced the following problems/side effects: diarrhoea, lethargy, metabolic acidosis, renal failure acute. MELOXICAM dosage: 7.5 MG; QD; PO. During the same period patient was treated with LISINOPRIL, LERCANIDIPINE, ALLOPURINOL, LANSOPRAZOLE, TIMOLOL MALEATE, MESALAZINE. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from reported MELOXICAM problem on Aug 30, 2007. Male patient, 49 years of age, was diagnosed with psoriatic arthropathy and was treated with MELOXICAM. After drug was administered, patient experienced the following problems/side effects: psoriasis. MELOXICAM dosage: unknown. Patient recovered.
MELOXICAM problem was reported by a Health Professional from UNITED KINGDOM on Sept 04, 2007. Male patient, 71 years of age, was diagnosed with gout and was treated with MELOXICAM. After drug was administered, patient experienced the following problems/side effects: dehydration, diarrhoea, dizziness, lethargy, metabolic acidosis, renal failure acute, renal impairment. MELOXICAM dosage: 7.5 MG; QD; PO. During the same period patient was treated with LISINOPRIL, LERCANIDIPINE, ALLOPURINOL, LANSOPRAZOLE, TIMOLOL MALEATE, MESALAZINE. Patient was hospitalized. Patient recovered.
Physician from UNITED KINGDOM reported MELOXICAM problem on Sept 13, 2007. Female patient, 82 years of age, was diagnosed with pain and was treated with MELOXICAM. After drug was administered, patient experienced the following problems/side effects: arteriosclerosis, aspiration, coronary artery disease, intestinal ischaemia, pericarditis. MELOXICAM dosage: 7.5 MG; QD; PO. During the same period patient was treated with DIGOXIN, OMEPRAZOLE, VITAMIN D, FOLIC ACID. Patient died.
MELOXICAM problem was reported by a Consumer or non-health professional from UNITED KINGDOM on Sept 12, 2007. Female patient, 82 years of age, was diagnosed with pain and was treated with MELOXICAM. After drug was administered, patient experienced the following problems/side effects: arteriosclerosis, aspiration, coronary artery disease, intestinal ischaemia, pericarditis. MELOXICAM dosage: unknown. During the same period patient was treated with CODEINE PHOSPHATE AND ACETAMINOPHEN, DIGOXIN, FOLIC ACID, OMEPRAZOLE, VITAMIN D. Patient died.
Consumer or non-health professional from UNITED KINGDOM reported MELOXICAM problem on Sept 13, 2007. Female patient, 82 years of age, was diagnosed with pain and was treated with MELOXICAM. After drug was administered, patient experienced the following problems/side effects: arteriosclerosis, aspiration, coronary artery disease, intestinal ischaemia, pericarditis. MELOXICAM dosage: 7.5 MG (7.5 MG, 1 IN 1 D) ORAL. Patient died.
This
drug has an active FDA Safety Alert